Neurological Biomarkers Market Report 2026
Download Free Sample Buy Now
Neurological Biomarkers Market Global Report 2026 Market Report Infographic Image
Item added to cart!

Published : January 2026

Pages :

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF
Purchase This Report

Neurological Biomarkers Market Report 2026

Global Outlook – By Product (Proteomics Biomarker, Genomics Biomarker, Metabolomics Biomarker, Imaging Biomarker, Other Products), By Application (Alzheimer’s Disease, Parkinson’s Disease, Huntington's Disease, Schizophrenia, Depression, Multiple Sclerosis, Spinal Muscular Atrophy), By End-User (Hospital Laboratories, Clinical Diagnostic Centers, Research Organizations, Other End-Users) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Neurological Biomarkers Market Overview

• Neurological Biomarkers market size has reached to $11.92 billion in 2025

• Expected to grow to $22.82 billion in 2030 at a compound annual growth rate (CAGR) of 14%

• Growth Driver: Rising Prevalence Of Neurological Diseases Fuels Momentum In Neurological Biomarker Market

• Market Trend: Revolutionizing Alzheimer's Disease Diagnosis And Patient Evaluation With Biomarker Blood Test

• North America was the largest region in 2025.

What Is Covered Under Neurological Biomarkers Market?

A neurological biomarker is a substance that provides objective and quantifiable information about the presence, progression, or characteristics of a neurological disorder or condition. They are used in clinical practice during drug development.

The main products of neurological biomarkers are proteomics biomarkers, genomics biomarkers, metabolomics biomarkers, imaging biomarkers, and others. Proteomics biomarkers refer to types of biomarkers that have specific proteins or patterns of proteins that can be identified and monitored by analyzing the proteins in the body fluid. They are used for various applications such as Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, schizophrenia, depression, multiple sclerosis, and spinal muscular atrophy by hospital laboratories, clinical diagnostic centers, research organizations, and others.

Neurological Biomarkers Market Global Report 2026 Market Report bar graph

What Is The Neurological Biomarkers Market Size and Share 2026?

The neurological biomarkers market size has grown rapidly in recent years. It will grow from $11.92 billion in 2025 to $13.52 billion in 2026 at a compound annual growth rate (CAGR) of 13.4%. The growth in the historic period can be attributed to rising prevalence of neurological disorders, early development of protein biomarkers, increased use of imaging biomarkers, growing adoption of dna biomarkers, initial integration of biomarkers in clinical trials.

What Is The Neurological Biomarkers Market Growth Forecast?

The neurological biomarkers market size is expected to see rapid growth in the next few years. It will grow to $22.82 billion in 2030 at a compound annual growth rate (CAGR) of 14.0%. The growth in the forecast period can be attributed to expanding use of biomarker-based personalized medicine, rising demand for metabolomics biomarkers, increasing investment in cns drug development, development of next-generation diagnostic platforms, growing application of biomarker-driven disease monitoring. Major trends in the forecast period include growing use of biomarkers in early neurological diagnosis, increasing adoption of proteomic and genomic biomarkers, expansion of imaging biomarkers in cns disorder evaluation, rising demand for biomarkers in drug development pipelines, growing clinical focus on neurodegenerative disease biomarker testing.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Neurological Biomarkers Market Segmentation

1) By Product: Proteomics Biomarker, Genomics Biomarker, Metabolomics Biomarker, Imaging Biomarker, Other Products

2) By Application: Alzheimer’s Disease, Parkinson’s Disease, Huntington's Disease, Schizophrenia, Depression, Multiple Sclerosis, Spinal Muscular Atrophy

3) By End-User: Hospital Laboratories, Clinical Diagnostic Centers, Research Organizations, Other End-Users

Subsegments:

1) By Proteomics Biomarker: Protein Biomarkers, Antibody Biomarkers

2) By Genomics Biomarker: DNA Biomarkers, RNA Biomarkers

3) By Metabolomics Biomarker: Metabolite Biomarkers, Lipid Biomarkers

4) By Imaging Biomarker: MRI Biomarkers, PET Scan Biomarkers

5) By Other Products: Neuroinflammatory Biomarkers, Neurotransmitter Biomarkers

What Is The Driver Of The Neurological Biomarkers Market?

The increasing prevalence of neurological diseases is expected to propel the growth of the neurological biomarker market going forward. Neurological illnesses affect the brain, spinal cord, and all of the body's other nerves. Parkinson's disease is a neurodegenerative disorder affecting the neurological system and the areas of the body that are under the control of the nerves. Neurological biomarkers help provide an early diagnosis of Parkinson's disease using pathological, biochemical, and genetic testing. For instance, in October 2023, according to the World Federation of Neurology, a UK-based charity, reflecting an accelerating global health burden, neurological disorders now represent the second-leading cause of death and the primary cause of disability worldwide, with more than 40 percent of the global population affected in 2023 and the number of individuals living with brain disease projected to nearly double by 2050. Therefore, the increasing prevalence of neurological diseases is driving the growth of the neurological biomarker industry.

Key Players In The Global Neurological Biomarkers Market

Major companies operating in the neurological biomarkers market are Pfizer Inc., F. Hoffmann-La Roche AG, Merck & Co. Inc., Novartis AG, Thermos Fisher Scientific Inc., AstraZeneca Plc, Abbott Laboratories, Boehringer Ingelheim International GmbH, Becton Dickinson and Company, Agilent Technologies Inc., Grifols S.A., Eisai Co. Ltd., PerkinElmer Inc., Illumina Inc., Shimadzu Corporation, Waters Corporation, Bio-Rad Laboratories Inc., Mallinckrodt Plc, Qiagen N.V., Luminex Corporation, Siemens Healthineers, Olink Proteomics, Meso Scale Diagnostics, Quanterix Corp., Fujirebio, Cisbio Bioassays SAS, NeuroVision Imaging, Proteome Sciences Plc, Acumen Pharmaceuticals.

Global Neurological Biomarkers Market Trends and Insights

Major companies operating in the neurological biomarkers market are developing new products such as advanced biomarker blood tests to gain a competitive edge in the market. Biomarker blood tests involve the analysis of specific molecules or indicators in the blood that provide information about a biological condition, disease, or physiological process. For instance, in July 2023, Quanterix Corporation, a US-based company that specializes in the development and commercialization of ultra-sensitive digital immunoassay platforms launched the LucentAD biomarker blood test. The LucentAD test is intended to assist medical professionals in evaluating patients who have cognitive symptoms that align with preliminary indications of alzheimer's disease. The test quantifies levels of p-Tau 181, which has been demonstrated to be a biomarker of the pathophysiology of alzheimer's disease (AD). When an adult is being tested for AD 1 and has cognitive impairment, the LucentAD test findings are meant to be utilized as a diagnostic tool. The test is not meant to be used as a stand-alone screening or diagnostic assay and it must be used in conjunction with other diagnostic tools.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Neurological Biomarkers Market?

In April 2024, GE HealthCare, a US-based medical technology company, acquired a MIM Software Inc. for an undisclosed amount. GE HealthCare aims to enhance precision care by integrating advanced imaging analytics and streamlining workflows, ultimately improving patient outcomes and clinician efficiency. This strategic move positions GE HealthCare to deliver more personalized treatment solutions across various medical specialties. MIM Software Inc., a US-based medical imaging software company, provides advanced imaging solutions that can enhance the identification and analysis of neurological biomarkers.

Regional Outlook

North America was the largest region in the neurological biomarkers market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Neurological Biomarkers Market?

The neurological biomarker market consists of sales of genetic testing kits, electroencephalography (EEG) devices, and biomarker assay kits. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Neurological Biomarkers Market Report 2026?

The neurological biomarkers market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the neurological biomarkers industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Neurological Biomarkers Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $13.52 billion
Revenue Forecast In 2035 $22.82 billion
Growth Rate CAGR of 13.4% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Product, Application, End-User
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Pfizer Inc., F. Hoffmann-La Roche AG, Merck & Co. Inc., Novartis AG, Thermos Fisher Scientific Inc., AstraZeneca Plc, Abbott Laboratories, Boehringer Ingelheim International GmbH, Becton Dickinson and Company, Agilent Technologies Inc., Grifols S.A., Eisai Co. Ltd., PerkinElmer Inc., Illumina Inc., Shimadzu Corporation, Waters Corporation, Bio-Rad Laboratories Inc., Mallinckrodt Plc, Qiagen N.V., Luminex Corporation, Siemens Healthineers, Olink Proteomics, Meso Scale Diagnostics, Quanterix Corp., Fujirebio, Cisbio Bioassays SAS, NeuroVision Imaging, Proteome Sciences Plc, Acumen Pharmaceuticals.
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Neurological Biomarkers Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Neurological Biomarkers Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Neurological Biomarkers Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Neurological Biomarkers Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Immersive Technologies (Ar/Vr/Xr) & Digital Experiences

4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.2. Major Trends

4.2.1 Growing Use Of Biomarkers In Early Neurological Diagnosis

4.2.2 Increasing Adoption Of Proteomic And Genomic Biomarkers

4.2.3 Expansion Of Imaging Biomarkers In Cns Disorder Evaluation

4.2.4 Rising Demand For Biomarkers In Drug Development Pipelines

4.2.5 Growing Clinical Focus On Neurodegenerative Disease Biomarker Testing

5. Neurological Biomarkers Market Analysis Of End Use Industries

5.1 Hospital Laboratories

5.2 Clinical Diagnostic Centers

5.3 Research Organizations

5.4 Biotechnology Companies

5.5 Pharmaceutical Companies

6. Neurological Biomarkers Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Neurological Biomarkers Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Neurological Biomarkers PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Neurological Biomarkers Market Size, Comparisons And Growth Rate Analysis

7.3. Global Neurological Biomarkers Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Neurological Biomarkers Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Neurological Biomarkers Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Neurological Biomarkers Market Segmentation

9.1. Global Neurological Biomarkers Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Proteomics Biomarker, Genomics Biomarker, Metabolomics Biomarker, Imaging Biomarker, Other Products

9.2. Global Neurological Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Alzheimer’s Disease, Parkinson’s Disease, Huntington's Disease, Schizophrenia, Depression, Multiple Sclerosis, Spinal Muscular Atrophy

9.3. Global Neurological Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospital Laboratories, Clinical Diagnostic Centers, Research Organizations, Other End-Users

9.4. Global Neurological Biomarkers Market, Sub-Segmentation Of Proteomics Biomarker, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Protein Biomarkers, Antibody Biomarkers

9.5. Global Neurological Biomarkers Market, Sub-Segmentation Of Genomics Biomarker, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

DNA Biomarkers, RNA Biomarkers

9.6. Global Neurological Biomarkers Market, Sub-Segmentation Of Metabolomics Biomarker, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Metabolite Biomarkers, Lipid Biomarkers

9.7. Global Neurological Biomarkers Market, Sub-Segmentation Of Imaging Biomarker, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

MRI Biomarkers, PET Scan Biomarkers

9.8. Global Neurological Biomarkers Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Neuroinflammatory Biomarkers, Neurotransmitter Biomarkers

10. Neurological Biomarkers Market Regional And Country Analysis

10.1. Global Neurological Biomarkers Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Neurological Biomarkers Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Neurological Biomarkers Market

11.1. Asia-Pacific Neurological Biomarkers Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Neurological Biomarkers Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Neurological Biomarkers Market

12.1. China Neurological Biomarkers Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Neurological Biomarkers Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Neurological Biomarkers Market

13.1. India Neurological Biomarkers Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Neurological Biomarkers Market

14.1. Japan Neurological Biomarkers Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Neurological Biomarkers Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Neurological Biomarkers Market

15.1. Australia Neurological Biomarkers Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Neurological Biomarkers Market

16.1. Indonesia Neurological Biomarkers Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Neurological Biomarkers Market

17.1. South Korea Neurological Biomarkers Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Neurological Biomarkers Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Neurological Biomarkers Market

18.1. Taiwan Neurological Biomarkers Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Neurological Biomarkers Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Neurological Biomarkers Market

19.1. South East Asia Neurological Biomarkers Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Neurological Biomarkers Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Neurological Biomarkers Market

20.1. Western Europe Neurological Biomarkers Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Neurological Biomarkers Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Neurological Biomarkers Market

21.1. UK Neurological Biomarkers Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Neurological Biomarkers Market

22.1. Germany Neurological Biomarkers Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Neurological Biomarkers Market

23.1. France Neurological Biomarkers Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Neurological Biomarkers Market

24.1. Italy Neurological Biomarkers Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Neurological Biomarkers Market

25.1. Spain Neurological Biomarkers Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Neurological Biomarkers Market

26.1. Eastern Europe Neurological Biomarkers Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Neurological Biomarkers Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Neurological Biomarkers Market

27.1. Russia Neurological Biomarkers Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Neurological Biomarkers Market

28.1. North America Neurological Biomarkers Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Neurological Biomarkers Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Neurological Biomarkers Market

29.1. USA Neurological Biomarkers Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Neurological Biomarkers Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Neurological Biomarkers Market

30.1. Canada Neurological Biomarkers Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Neurological Biomarkers Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Neurological Biomarkers Market

31.1. South America Neurological Biomarkers Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Neurological Biomarkers Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Neurological Biomarkers Market

32.1. Brazil Neurological Biomarkers Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Neurological Biomarkers Market

33.1. Middle East Neurological Biomarkers Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Neurological Biomarkers Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Neurological Biomarkers Market

34.1. Africa Neurological Biomarkers Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Neurological Biomarkers Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Neurological Biomarkers Market Regulatory and Investment Landscape

36. Neurological Biomarkers Market Competitive Landscape And Company Profiles

36.1. Neurological Biomarkers Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Neurological Biomarkers Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Neurological Biomarkers Market Company Profiles

36.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Neurological Biomarkers Market Other Major And Innovative Companies

AstraZeneca Plc, Abbott Laboratories, Boehringer Ingelheim International GmbH, Becton Dickinson and Company, Agilent Technologies Inc., Grifols S.A., Eisai Co. Ltd., PerkinElmer Inc., Illumina Inc., Shimadzu Corporation, Waters Corporation, Bio-Rad Laboratories Inc., Mallinckrodt Plc, Qiagen N.V., Luminex Corporation

38. Global Neurological Biomarkers Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Neurological Biomarkers Market

40. Neurological Biomarkers Market High Potential Countries, Segments and Strategies

40.1 Neurological Biomarkers Market In 2030 - Countries Offering Most New Opportunities

40.2 Neurological Biomarkers Market In 2030 - Segments Offering Most New Opportunities

40.3 Neurological Biomarkers Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Neurological Biomarkers Market, Overview Of Key Products - Product Examples
  • Table 2: Global Neurological Biomarkers Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Neurological Biomarkers Market, Supply Chain Analysis
  • Table 4: Global Neurological Biomarkers Market, Major Raw Material Providers
  • Table 5: Global Neurological Biomarkers Market, Major Resource Providers
  • Table 6: Global Neurological Biomarkers Market, Major Manufacturers (Suppliers)
  • Table 7: Global Neurological Biomarkers Market, Major Distributors And Channel Partners
  • Table 8: Global Neurological Biomarkers Market, Key Technologies & Future Trends
  • Table 9: Global Neurological Biomarkers Market, Major Trends
  • Table 10: Global Neurological Biomarkers Market, Major End Users
  • Table 11: Global Neurological Biomarkers Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Neurological Biomarkers Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Neurological Biomarkers Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Neurological Biomarkers Market - TAM, US$ Billion, 2025
  • Table 15: Global Neurological Biomarkers Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Neurological Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Neurological Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Neurological Biomarkers Market, Sub-Segmentation Of Proteomics Biomarker, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Neurological Biomarkers Market, Sub-Segmentation Of Genomics Biomarker, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Neurological Biomarkers Market, Sub-Segmentation Of Metabolomics Biomarker, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Neurological Biomarkers Market, Sub-Segmentation Of Imaging Biomarker, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Global Neurological Biomarkers Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Global Neurological Biomarkers Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Global Neurological Biomarkers Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: Asia-Pacific, Neurological Biomarkers Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: Asia-Pacific, Neurological Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: Asia-Pacific, Neurological Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: China, Neurological Biomarkers Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: China, Neurological Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: China, Neurological Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: India, Neurological Biomarkers Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: India, Neurological Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: India, Neurological Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Japan, Neurological Biomarkers Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Japan, Neurological Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Japan, Neurological Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Australia, Neurological Biomarkers Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Australia, Neurological Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Australia, Neurological Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Indonesia, Neurological Biomarkers Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: Indonesia, Neurological Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: Indonesia, Neurological Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: South Korea, Neurological Biomarkers Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: South Korea, Neurological Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: South Korea, Neurological Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: Taiwan, Neurological Biomarkers Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: Taiwan, Neurological Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: Taiwan, Neurological Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: South East Asia, Neurological Biomarkers Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: South East Asia, Neurological Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: South East Asia, Neurological Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: Western Europe, Neurological Biomarkers Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: Western Europe, Neurological Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: Western Europe, Neurological Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: UK, Neurological Biomarkers Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: UK, Neurological Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: UK, Neurological Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: Germany, Neurological Biomarkers Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: Germany, Neurological Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: Germany, Neurological Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: France, Neurological Biomarkers Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: France, Neurological Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: France, Neurological Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: Italy, Neurological Biomarkers Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Italy, Neurological Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Italy, Neurological Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Spain, Neurological Biomarkers Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Spain, Neurological Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Spain, Neurological Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Eastern Europe, Neurological Biomarkers Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Eastern Europe, Neurological Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Eastern Europe, Neurological Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: Russia, Neurological Biomarkers Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: Russia, Neurological Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: Russia, Neurological Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: North America, Neurological Biomarkers Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: North America, Neurological Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: North America, Neurological Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: USA, Neurological Biomarkers Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: USA, Neurological Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: USA, Neurological Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: Canada, Neurological Biomarkers Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: Canada, Neurological Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: Canada, Neurological Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: South America, Neurological Biomarkers Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: South America, Neurological Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: South America, Neurological Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: Brazil, Neurological Biomarkers Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: Brazil, Neurological Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Brazil, Neurological Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Middle East, Neurological Biomarkers Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Middle East, Neurological Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Middle East, Neurological Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Africa, Neurological Biomarkers Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 95: Africa, Neurological Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 96: Africa, Neurological Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 97: Global Neurological Biomarkers Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 98: Global Neurological Biomarkers Market - Company Scoring Matrix
  • Table 99: Pfizer Inc. Financial Performance
  • Table 100: F. Hoffmann-La Roche AG Financial Performance
  • Table 101: Merck & Co. Inc. Financial Performance
  • Table 102: Novartis AG Financial Performance
  • Table 103: Thermo Fisher Scientific Inc. Financial Performance
  • Table 104: Global Neurological Biomarkers Market, Competitive Benchmarking (In USD Billions)
  • Table 105: Global Neurological Biomarkers Market, Competitive Dashboard
  • Table 106: Global Neurological Biomarkers Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 107: Global, Neurological Biomarkers Market Size Gain ($ Billion), Segmentation By Product, 2025 – 2030
  • Table 108: Global, Neurological Biomarkers Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030
  • Table 109: Global, Neurological Biomarkers Market Size Gain ($ Billion), Segmentation By End-User, 2025 – 2030

List Of Figures

    Figure 1: Global Neurological Biomarkers Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Neurological Biomarkers Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Neurological Biomarkers Market, Supply Chain Analysis
  • Figure 4: Global Neurological Biomarkers Market, Major Raw Material Providers
  • Figure 5: Global Neurological Biomarkers Market, Major Resource Providers
  • Figure 6: Global Neurological Biomarkers Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Neurological Biomarkers Market, Major Distributors And Channel Partners
  • Figure 8: Global Neurological Biomarkers Market, Key Technologies & Future Trends
  • Figure 9: Global Neurological Biomarkers Market, Major Trends
  • Figure 10: Global Neurological Biomarkers Market, Major End Users
  • Figure 11: Global Neurological Biomarkers Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Neurological Biomarkers Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Neurological Biomarkers Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Neurological Biomarkers Market - TAM, US$ Billion, 2025
  • Figure 15: Global Neurological Biomarkers Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Neurological Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Neurological Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Neurological Biomarkers Market, Sub-Segmentation Of Proteomics Biomarker, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Neurological Biomarkers Market, Sub-Segmentation Of Genomics Biomarker, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Neurological Biomarkers Market, Sub-Segmentation Of Metabolomics Biomarker, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Neurological Biomarkers Market, Sub-Segmentation Of Imaging Biomarker, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Global Neurological Biomarkers Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Global Neurological Biomarkers Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Global Neurological Biomarkers Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: Asia-Pacific, Neurological Biomarkers Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: Asia-Pacific, Neurological Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: Asia-Pacific, Neurological Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: China, Neurological Biomarkers Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: China, Neurological Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: China, Neurological Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: India, Neurological Biomarkers Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: India, Neurological Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: India, Neurological Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Japan, Neurological Biomarkers Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Japan, Neurological Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Japan, Neurological Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Australia, Neurological Biomarkers Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Australia, Neurological Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Australia, Neurological Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Indonesia, Neurological Biomarkers Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: Indonesia, Neurological Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: Indonesia, Neurological Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: South Korea, Neurological Biomarkers Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: South Korea, Neurological Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: South Korea, Neurological Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: Taiwan, Neurological Biomarkers Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: Taiwan, Neurological Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: Taiwan, Neurological Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: South East Asia, Neurological Biomarkers Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: South East Asia, Neurological Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: South East Asia, Neurological Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: Western Europe, Neurological Biomarkers Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: Western Europe, Neurological Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: Western Europe, Neurological Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: UK, Neurological Biomarkers Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: UK, Neurological Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: UK, Neurological Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: Germany, Neurological Biomarkers Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: Germany, Neurological Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: Germany, Neurological Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: France, Neurological Biomarkers Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: France, Neurological Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: France, Neurological Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: Italy, Neurological Biomarkers Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Italy, Neurological Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Italy, Neurological Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Spain, Neurological Biomarkers Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Spain, Neurological Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Spain, Neurological Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Eastern Europe, Neurological Biomarkers Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Eastern Europe, Neurological Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Eastern Europe, Neurological Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: Russia, Neurological Biomarkers Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: Russia, Neurological Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: Russia, Neurological Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: North America, Neurological Biomarkers Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: North America, Neurological Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: North America, Neurological Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: USA, Neurological Biomarkers Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: USA, Neurological Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: USA, Neurological Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: Canada, Neurological Biomarkers Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: Canada, Neurological Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: Canada, Neurological Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: South America, Neurological Biomarkers Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: South America, Neurological Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: South America, Neurological Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: Brazil, Neurological Biomarkers Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: Brazil, Neurological Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Brazil, Neurological Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Middle East, Neurological Biomarkers Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Middle East, Neurological Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Middle East, Neurological Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Africa, Neurological Biomarkers Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 95: Africa, Neurological Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 96: Africa, Neurological Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 97: Global Neurological Biomarkers Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 98: Global Neurological Biomarkers Market - Company Scoring Matrix
  • Figure 99: Pfizer Inc. Financial Performance
  • Figure 100: F. Hoffmann-La Roche AG Financial Performance
  • Figure 101: Merck & Co. Inc. Financial Performance
  • Figure 102: Novartis AG Financial Performance
  • Figure 103: Thermo Fisher Scientific Inc. Financial Performance
  • Figure 104: Global Neurological Biomarkers Market, Competitive Benchmarking (In USD Billions)
  • Figure 105: Global Neurological Biomarkers Market, Competitive Dashboard
  • Figure 106: Global Neurological Biomarkers Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 107: Global, Neurological Biomarkers Market Size Gain ($ Billion), Segmentation By Product, 2025 – 2030
  • Figure 108: Global, Neurological Biomarkers Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030
  • Figure 109: Global, Neurological Biomarkers Market Size Gain ($ Billion), Segmentation By End-User, 2025 – 2030

Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

Read More About Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Read More About 2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Read More About Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

Read More About Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

Read More About A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

Read More About A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

Read More About A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

Explore strategic insights and forecasts in the global virtual nutrition coach app market, offering competitive benchmarking and market growth trends.

Read More About Explore strategic insights and forecasts in the global virtual nutrition coach app market, offering competitive benchmarking and market growth trends.

Neurological Biomarkers Market Report 2026 - Global Outlook – By Product (Proteomics Biomarker, Genomics Biomarker, Metabolomics Biomarker, Imaging Biomarker, Other Products), By Application (Alzheimer’s Disease, Parkins...

Central Nervous System Biomarkers Market Report 2026 - Global Outlook – By Type (Safety Biomarker, Efficacy Biomarker, Validation Biomarker, Other Types), By Disease (Multiple Sclerosis, Alzheimer's Disease, Parkinson's ...

Clinical Biomarkers Market Report 2026 - Global Outlook – By Offering (Product, Service), By Technology (Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Immunohistochemistry (IHC), Enzyme-Linked Immuno...

Biomarkers Market Report 2026 - Global Outlook – By Technology (Safety Biomarkers, Efficacy Biomarkers, Validation Biomarkers), By Disease (Neurological Diseases, Cancer, Immunological Diseases, Cardiovascular Diseases, ...

Neurological Disorder Drugs Market Report 2026 - Global Outlook – By Drug Class (Cholinesterase Inhibitors, N-Methyl-D-Aspartate (NMDA) Receptor Antagonists, Antiepileptic, Antipsychotic And Antidepressant, Other Drugs C...

Neuroscience Antibodies & Assays Market Report 2026 - Global Outlook – By Product (Consumables, Instruments), By Technology (Molecular Diagnostics, Immunoassays Or Immunochemistry, Other Technologies), By Application (In...

Neurology Monitoring Market Report 2026 - Global Outlook – By Product Type (Magnetic Resonance Imaging (MRI) Devices, Electroencephalography Devices, Cerebral Oximeters, Intracranial Pressure Monitors, Other Product Type...

Cancer Biomarker Market Report 2026 - Global Outlook – By Biomarker Type (Protein Biomarkers, Genetic Biomarkers, Other Biomarker Types), By Profiling Technologies (Omics Technologies, Immunoassay, Bioinformatics, Cytoge...

Frequently Asked Questions

The Neurological Biomarkers Market Report 2026 market was valued at $11.92 billion in 2025, increased to $13.52 billion in 2026, and is projected to reach $22.82 billion by 2030. request a sample here

The expected CAGR for the Neurological Biomarkers Market Report 2026 market during the forecast period 2025–2030 is 14.0%. request a sample here

Major growth driver of the market includes: Rising Prevalence Of Neurological Diseases Fuels Momentum In Neurological Biomarker Market in the Neurological Biomarkers Market Report 2026 market. For further insights on this market, request a sample here

The neurological biomarkers market covered in this report is segmented –
1) By Product: Proteomics Biomarker, Genomics Biomarker, Metabolomics Biomarker, Imaging Biomarker, Other Products
2) By Application: Alzheimer’s Disease, Parkinson’s Disease, Huntington's Disease, Schizophrenia, Depression, Multiple Sclerosis, Spinal Muscular Atrophy
3) By End-User: Hospital Laboratories, Clinical Diagnostic Centers, Research Organizations, Other End-Users Subsegments:
1) By Proteomics Biomarker: Protein Biomarkers, Antibody Biomarkers
2) By Genomics Biomarker: DNA Biomarkers, RNA Biomarkers
3) By Metabolomics Biomarker: Metabolite Biomarkers, Lipid Biomarkers
4) By Imaging Biomarker: MRI Biomarkers, PET Scan Biomarkers
5) By Other Products: Neuroinflammatory Biomarkers, Neurotransmitter Biomarkers request a sample here

Major trend in this market includes: Revolutionizing Alzheimer's Disease Diagnosis And Patient Evaluation With Biomarker Blood Test For further insights on this market, request a sample here.

Major companies operating in the Neurological Biomarkers Market Report 2026 market are Major companies operating in the neurological biomarkers market are Pfizer Inc., F. Hoffmann-La Roche AG, Merck & Co. Inc., Novartis AG, Thermos Fisher Scientific Inc., AstraZeneca Plc, Abbott Laboratories, Boehringer Ingelheim International GmbH, Becton Dickinson and Company, Agilent Technologies Inc., Grifols S.A., Eisai Co. Ltd., PerkinElmer Inc., Illumina Inc., Shimadzu Corporation, Waters Corporation, Bio-Rad Laboratories Inc., Mallinckrodt Plc, Qiagen N.V., Luminex Corporation, Siemens Healthineers, Olink Proteomics, Meso Scale Diagnostics, Quanterix Corp., Fujirebio, Cisbio Bioassays SAS, NeuroVision Imaging, Proteome Sciences Plc, Acumen Pharmaceuticals. request a sample here.

North America was the largest region in the neurological biomarkers market in 2025. The regions covered in the neurological biomarkers market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us